Treasury Blacklists More Folks: Hands Off Their U.S. Cash
Published Date: 8/26/2025
Notice
Summary
The U.S. Treasury’s OFAC just added new people to its blacklist, meaning their money and property in the U.S. are frozen. Americans can’t do business with these folks anymore. This move helps keep bad actors out of the U.S. financial system, and it’s effective immediately.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
New OFAC SDN Listings Freeze Assets
The Treasury’s OFAC added one or more people to the Specially Designated Nationals and Blocked Persons (SDN) List. All of those persons’ property and interests in property subject to U.S. jurisdiction are blocked, and U.S. persons are generally prohibited from engaging in transactions with them. This action is effective immediately.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13494 — Notice of OFAC Sanctions Actions
The U.S. Treasury’s OFAC just blocked the property of Oscar Guillermo Juraidini Silva from Mexico for his role in illegal drug trade and terrorism. This means U.S. people can’t do business with him, and any money or assets he has under U.S. control are frozen. These sanctions took effect on June 30, 2026, tightening the squeeze on global crime and terrorism funding.
2026-13363 — Notice of OFAC Sanctions Actions
The U.S. Treasury’s Office of Foreign Assets Control (OFAC) updated some names on its sanctions lists to fix errors and make the info clearer. These changes affect people and groups already on the lists, helping keep things accurate and consistent. The updates took effect on June 25, 2026, ensuring the sanctions stay sharp and effective.
2026-13389 — Notice of OFAC Sanctions Action
The U.S. Treasury’s Office of Foreign Assets Control (OFAC) just added new people to its blacklist, meaning their money and property in the U.S. are frozen. Americans can’t do business with these folks anymore, starting from May 28, 2026. This move aims to stop bad actors from using the U.S. financial system and could impact any money tied to them.
2026-13387 — Notice of OFAC Sanctions Action
The U.S. Treasury’s Office of Foreign Assets Control (OFAC) just added one person to its special sanctions list, meaning all their U.S.-based money and property are frozen. Americans can’t do business with this person anymore, starting from May 27, 2026. This move aims to block bad actors and protect U.S. interests with no delay.
2026-13388 — Notice of OFAC Sanctions Action
The U.S. Treasury’s Office of Foreign Assets Control (OFAC) just added certain people and ships to its blacklist, meaning their U.S.-based money and property are frozen. Americans can’t do business with them anymore, starting June 5, 2026. This move aims to block bad actors and protect U.S. interests by cutting off their access to U.S. dollars and assets.
2026-13278 — Notice of OFAC Sanctions Action
The U.S. Treasury’s OFAC just blocked the property of two Rwandan men linked to conflict-related activities in the Democratic Republic of the Congo. From June 25, 2026, Americans can’t do business with them, freezing their U.S.-based assets and cutting off money flows. This move aims to stop funding that fuels conflict and sends a clear message about accountability.
Previous / Next Documents
Previous: 2025-16226 — National Human Genome Research Institute; Amended Notice of Meeting
The National Human Genome Research Institute changed the meeting time for its advisory council on September 16, 2025. The meeting now starts at 9:30 a.m. and ends at 2:30 p.m., instead of the original 9:00 a.m. to 1:00 p.m. This update affects anyone interested in attending or following the meeting, with no changes to costs or location.
Next: 2025-16265 — Determination of Regulatory Review Period for Purposes of Patent Extension; IQIRVO
The FDA has officially set the review period for IQIRVO, a human drug product, so its patent can be extended. This helps the company behind IQIRVO get extra time to protect their invention after going through the FDA’s approval process. If you’re involved in drug patents or development, this means important deadlines and opportunities to keep an invention exclusive just got clearer.